March 01, 2017
A former ArthroCare Corp. executive accused of participating in a $750 million securities fraud scheme who was granted a new trial by the Fifth Circuit asked a Texas federal judge on Tuesday to enforce that decision, alleging that the U.S. Department of Justice and U.S. Securities and Exchange Commission were working together to go around it.
December 08, 2014
A Texas federal judge on Friday denied a bid for a new trial by Michael Baker and Michael Gluk, the former CEO and CFO of ArthroCare Corp., rejecting the argument that their constitutional right to a public trial was violated when their family members couldn't find seats in court to view jury selection.
December 04, 2014
Federal prosecutors on Thursday denied claims from two former ArthroCare Inc. executives convicted for an estimated $756 million earnings-fraud scheme that their family and members of the public were wrongly excluded from the courtroom so that attorneys favoring the prosecution could enjoy preferential seating, saying their arguments were meritless.
December 03, 2014
ArthroCare Corp.'s former chief financial officer on Tuesday joined a motion for a new trial filed by the company's ex-CEO, who says his conviction for an estimated $756 million earnings-fraud scheme was tainted by a deal-breaking mistake during the jury selection process.
November 24, 2014
Convicted former ArthroCare Corp. CEO Michael Baker is asking a Texas federal court to grant him a new trial, saying his conviction for an estimated $756 million earnings-fraud scheme was tainted by a deal-breaking mistake during the jury selection process.
August 25, 2014
The U.S. Department of Justice is asking for decadeslong sentences for two ArthroCare Corp. execs convicted in Texas federal court of perpetrating a securities fraud that the government is now measuring at $958.4 million, saying the two lied under oath and have shown no remorse for their machinations.
July 02, 2014
A Texas federal judge on Wednesday refused to acquit or grant new trials for two of ArthroCare Corp.'s top executives convicted for their roles in a $400 million fraud scheme to inflate the medical device maker's earnings, finding the evidence amply supported their verdicts.
June 02, 2014
A Texas federal jury on Monday returned convictions for ArthroCare Corp.'s two top executives for their roles in a $400 million fraud on shareholders through a scheme to inflate the medical device maker's earnings, federal prosecutors said.
May 29, 2014
A Texas federal judge has refused to acquit ArthroCare Corp.'s former CEO and chief financial officer of charges that they perpetrated a $400 million fraud on shareholders through a scheme to inflate the medical device maker's earnings, according to court documents made public Thursday.